Dietary Green Tea Confection For Resolving Gut Permeability-Induced Metabolic Endotoxemia In Obese Adults

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-08-29

Study Completion Date

2019-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is focused on assessing gastrointestinal-level improvements by which green tea limits metabolic endotoxemia. It is completed in two phases. Phase I consists of a pharmacokinetic study to examine the bioavailability of green tea catechins among lean and obese persons who consumed a single dose of a green tea extract (GTE)-containing confection. These persons will then complete phase 2, which consists of a parallel design randomized controlled in which lean and obese persons will consume placebo or GTE confections.

It is expected that catechin-rich green tea will improve gut barrier function to prevent endotoxin translocation and associated low-grade inflammation. Outcomes will therefore support dietary recommendations for green tea to alleviate obesity-related inflammatory responses. Specifically, the study is expected to demonstrate that a green tea confection snack food can attenuate metabolic endotoxemia in association with restoring gastrointestinal health.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-term Effects of Green Tea on Gut Flora, Fat Absorption, Body Composition and Resting Energy Expenditure

NCT01556321

Obesity

COMPLETED NA

Effects of Green Tea on Body Weight Reduction and Gut Microbiota

NCT03537625

Obesity

COMPLETED NA

Evaluation of Metabolism-Boosting Beverages

NCT01029236

Energy Expenditure Appetite

COMPLETED NA

Effect of Cranberry and Agaves Extract on Microbiota and Intestinal Health

NCT03800277

Endotoxemia Metabolic Syndrome Glucose Metabolism Disorders +1 more

COMPLETED NA

The Role of Tea Catechins and Caffeine in Relation to Energy Metabolism

NCT00611416

Obesity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Obesity is a major public health concern in the United States, with over two-thirds of the adult population classified as overweight or obese. Obesity is characterized by low-grade chronic inflammation that, in part, is mediated by metabolic endotoxemia. Metabolic endotoxemia describes increased circulating levels of gut-derived endotoxin (a bacterial product derived from Gram-negative bacteria in the intestines) that results from gut barrier dysfunction, a phenomenon that is common in obesity. Studies in rodents models have shown that dietary supplementation with green tea extract (GTE) reduces metabolic endotoxemia in association with improved gut health. This clinical trial will therefore investigate the extent to which a green tea confection snack food can alleviate metabolic endotoxemia and restore gut health in obese humans. It is hypothesized that 4-week daily ingestion of a green tea extract (GTE)-rich confection will limit metabolic endotoxemia by decreasing gut barrier permeability. This study will address the following objectives: 1) define alterations in catechin pharmacokinetics in obese compared with healthy adults, 2) demonstrate improvements in gut barrier function by GTE, and 3) demonstrate GTE-mediated amelioration of microbial dysbiosis.

To test the hypothesis, all participants will initially complete a 12-h pharmacokinetics study to define the influence of obesity on catechin bioavailability and metabolism. They will then be randomized to complete a double-blind, randomized, placebo-controlled trial where they will receive a GTE-rich or placebo confection for 4 weeks. Prior to and upon completing the intervention, participants will undergo a gut permeability test, fecal samples will be collected for microbiota composition analysis, and blood samples will be collected to assess endotoxin and inflammatory biomarkers. Upon successfully completing this study, it is anticipated that chronic consumption of a green tea confection will be demonstrated to be an effective dietary strategy to reduce metabolic endotoxemia and improve gut health.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Endotoxemia Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo Confection

Confection without green tea extract consumed daily for 4 weeks

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Confections containing no green tea extract that will be ingested daily for 4 weeks

Green Tea Extract-Confection

Confection with green tea extract consumed daily for 4 weeks

Group Type EXPERIMENTAL

Green Tea Extract

Intervention Type OTHER

Confections containing green tea extract that will be ingested daily for 4 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Green Tea Extract

Confections containing green tea extract that will be ingested daily for 4 weeks

Intervention Type OTHER

Placebo

Confections containing no green tea extract that will be ingested daily for 4 weeks

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Overweight/obese (BMI = 28-40 kg/m2)
* Fasting glucose \< 126 mg/dL
* Normotensive (blood pressure \< 140/90 mmHg)
* Non-dietary supplement user
* Non-smoker

Exclusion Criteria

* Regular tea drinkers (\> 2 cups/week)
* Vegetarians
* Use of medications to manage diabetes, hypertension, or hyperlipidemia
* Use of any medications known to be contraindicated for use with green tea ingestion
* User of dietary supplements, prebiotics, or probiotics
* Recent use of antibiotics or anti-inflammatory agents
* Women who are pregnant or lactating or have initiated or changed birth control in the past 3-months
* Individuals with gastrointestinal disorders or surgeries
* Individuals with hemochromatosis
* Alcohol intake \> 3 drinks per day
* Any history of cancer

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes